Tables and figures
Table 1: Characteristics of study populations, with proportions
admitted/discharged and re-presentation rates for ED discharges (with
univariable regression analysis).
Table 2: Intranasal management strategies for ED patients.
Table 3: Outcomes following re-presentation by intranasal
management
Figure 1: Combination graphic to communicate trends in data
over 12-week audit period: 1) The bar chart forming the background shows
sequential opening of centres across the UK as the audit period
progressed, 2) The box and whisker plots show the median, range and
interquartile range of epistaxis patients presenting per centre per week
for each of the three 4-week audit periods, 3) The scatter plot and
error bars are COVID-19 swab rates (%) (diamonds) and positive swab
rates (%) (crosses) with 95% confidence intervals, 4) The grey line
chart is the 7-day rolling average of UK cases from 1st March to 31st
July (available at:https://coronavirus.data.gov.uk/cases).
Figure 2: Sankey chart visualising proportions of patients
being admitted or discharged from the ED, with rates of subsequent
re-presentation, stratified by definitive intranasal management.